Impact Biomedical holds special shareholder meeting
IBO•Impact Biomedical shareholders approved an amended merger and share exchange agreement and other proposals at a special meeting on November 13, 2026.
1. Shareholders approve proposals
Shareholders approved the amended merger and share exchange agreement, adopted amended and restated articles of association, and elected all eight director nominees. They also ratified Grassi & Co. Certified Public Accountants as independent auditor for the fiscal year ending December 31, 2026; an authorized adjournment was unnecessary because sufficient votes were received.




